Sign in
Active, not recruitingPhase 3

Post-exposure Influenza Prophylaxis in a Hospital Setting

Key facts

Who runs it
University Medical Centre Ljubljana
Where
Slovenia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 3
People taking part
200 people, planned
Started
1 Dec 2025
Expected to end
31 Mar 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Oseltamivir
Record updated
30 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • 18 years or older
  • exposure to influenza during hospitalization
  • risk factors for influenza complications
  • consent for participation obtained

Who cannot take part

  • hematological malignancy
  • younger than 18 years
  • hospitalized in intensive care unit
  • refusal to participate

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to compare the efficacy of 5-day versus 10-day oseltamivir prophylactic treatment in patients who had been exposed to influenza in a hospital setting.

The 2 groups in the trial

  • oseltamivir 5 daysExisting treatment, for comparison

    post-exposure influenza prophylaxis with oseltamivir for 5 days

    Treatment: Oseltamivir

  • oseltamivir 10 daysExisting treatment, for comparison

    post-exposure influenza prophylaxis with oseltamivir for 10 days

    Treatment: Oseltamivir

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Post-Exposure Influenza Chemoprophylaxis With Oseltamivir for Five Days vs Ten Days in Acute-Care Hospital: a Non-Inferiority Randomized Open-Label Study
Record updated
30 April 2026